Janssen Biotech Inc.

09/10/2024 | Press release | Distributed by Public on 09/10/2024 15:42

Dexamethasone reduces infusion related reactions in patients with EGFR mutated non small cell lung cancer treated with intravenous RYBREVANT® (amivantamab vmjw)